BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30804341)

  • 1. Disturbed homocysteine metabolism is associated with cancer.
    Hasan T; Arora R; Bansal AK; Bhattacharya R; Sharma GS; Singh LR
    Exp Mol Med; 2019 Feb; 51(2):1-13. PubMed ID: 30804341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide attenuates homocysteine-induced cognitive deficits and neurochemical alterations by improving endogenous hydrogen sulfide levels.
    Kumar M; Modi M; Sandhir R
    Biofactors; 2017 May; 43(3):434-450. PubMed ID: 28394038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice.
    Jakubowski H; Perla-Kaján J; Finnell RH; Cabrera RM; Wang H; Gupta S; Kruger WD; Kraus JP; Shih DM
    FASEB J; 2009 Jun; 23(6):1721-7. PubMed ID: 19204075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine and Hyperhomocysteinaemia.
    Zaric BL; Obradovic M; Bajic V; Haidara MA; Jovanovic M; Isenovic ER
    Curr Med Chem; 2019; 26(16):2948-2961. PubMed ID: 29532755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia abrogates fasting-induced cardioprotection against ischemia/reperfusion by limiting bioavailability of hydrogen sulfide anions.
    Nakano S; Ishii I; Shinmura K; Tamaki K; Hishiki T; Akahoshi N; Ida T; Nakanishi T; Kamata S; Kumagai Y; Akaike T; Fukuda K; Sano M; Suematsu M
    J Mol Med (Berl); 2015 Aug; 93(8):879-89. PubMed ID: 25740079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia.
    Sen U; Sathnur PB; Kundu S; Givvimani S; Coley DM; Mishra PK; Qipshidze N; Tyagi N; Metreveli N; Tyagi SC
    Am J Physiol Cell Physiol; 2012 Jul; 303(1):C41-51. PubMed ID: 22517358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.
    Zoccolella S; Martino D; Defazio G; Lamberti P; Livrea P
    Curr Vasc Pharmacol; 2006 Jul; 4(3):237-43. PubMed ID: 16842141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia as a risk factor for the neuronal system disorders.
    Petras M; Tatarkova Z; Kovalska M; Mokra D; Dobrota D; Lehotsky J; Drgova A
    J Physiol Pharmacol; 2014 Feb; 65(1):15-23. PubMed ID: 24622826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of Homocysteine and H
    Yang Q; He GW
    Oxid Med Cell Longev; 2019; 2019():7629673. PubMed ID: 31885816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine in venous thromboembolism.
    Brattström L; Tengborn L; Lagerstedt C; Israelsson B; Hultberg B
    Haemostasis; 1991; 21(1):51-7. PubMed ID: 1864556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modulation of homocysteinemia.
    Rozen R
    Semin Thromb Hemost; 2000; 26(3):255-61. PubMed ID: 11011843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
    Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
    FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tube defects and a disturbed folate dependent homocysteine metabolism.
    van der Put NM; Blom HJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):57-61. PubMed ID: 10986435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease.
    Malinowska A; Chmurzynska A
    Nutr Res; 2009 Oct; 29(10):685-95. PubMed ID: 19917447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nephrotic syndrome on homocysteine metabolism.
    Aminzadeh MA; Gollapudi P; Vaziri ND
    Nephrol Dial Transplant; 2011 Apr; 26(4):1244-7. PubMed ID: 20826746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new link between high homocysteine levels, cancers and neurodegenerative diseases].
    Padovani D
    Med Sci (Paris); 2017 May; 33(5):494-497. PubMed ID: 28612724
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics.
    Blasco C; Caballería J; Deulofeu R; Lligoña A; Parés A; Lluis JM; Gual A; Rodés J
    Alcohol Clin Exp Res; 2005 Jun; 29(6):1044-8. PubMed ID: 15976531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.